| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/14/2004 | CN1512992A Novel adenine derivatives |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512889A Pharmaceutial and/or cosmtic compositions for treatment of localised adiposities and cellulite |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512868A Methods of preventing UVB-induced skin damage |
| 07/14/2004 | CN1511838A Triptolide alcohol derivative and its use |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511579A Chinese medicine preparation |
| 07/14/2004 | CN1511561A Bed sore ointment |
| 07/14/2004 | CN1511560A Method for producing bed sore ointment |
| 07/14/2004 | CN1511559A Powder for removing necrotic tissue and tissue regeneration |
| 07/14/2004 | CN1511558A Method for producing necotric tissue removing and tissue regeneration powder |
| 07/14/2004 | CN1511543A Fast curnig powder for inflammation and swelling |
| 07/14/2004 | CN1511533A Use of bufadienolide in inhibiting vascularization |
| 07/14/2004 | CN1511531A Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 07/14/2004 | CN1511526A Rifaximin ointment |
| 07/14/2004 | CN1511521A Use of goldenlarch bark acetic acid inhibiting vascularization |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1511475A Edible vinegar beauty health food and its producing method |
| 07/14/2004 | CN1157404C Novel fusidic acid derivatives |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157217C Spraying medicine for treating tinea pedis and process for making same |
| 07/14/2004 | CN1157216C Toxic substance removing ointment and its preparing method |
| 07/14/2004 | CN1157210C Medicinal composition containing aloe and its preparing process and application |
| 07/14/2004 | CN1157203C Chinese medicine external use lotion for treating skin diseases and its preparing method |
| 07/14/2004 | CN1157193C Lotion for treating anal fistula and gynopathy |
| 07/14/2004 | CN1157183C Calamine lotion |
| 07/14/2004 | CN1157181C Use of conjugated linoleic acid (CLA) for topical treatment of cellulite |
| 07/14/2004 | CN1157180C Pure traditional Chinese medicine cosmetic |
| 07/14/2004 | CN1157178C Composition for enhancing skin or hair |
| 07/14/2004 | CN1157176C Germinal liniment |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762164 Use of 3-position cyclosporin derivatives for hair growth |
| 07/13/2004 | US6762158 Personal care compositions comprising liquid ester mixtures |
| 07/13/2004 | CA2375537C Topically applied idebenone-containing agent with protective and regenerative effect |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/08/2004 | WO2004056991A2 Novel angiogenic molecular target and uses thereof |
| 07/08/2004 | WO2004056836A1 Silicon-containing compounds and their use |
| 07/08/2004 | WO2004056827A2 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/08/2004 | WO2004056809A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056808A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056773A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056762A2 Novel aminobenzophenone compounds |
| 07/08/2004 | WO2004056383A1 Herbal composition for cuts, burns and wounds |
| 07/08/2004 | WO2004056368A1 Therapeutic applications of 2-substituted 4-heteroarylryrimidines |
| 07/08/2004 | WO2004056307A2 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | WO2004043424A8 Method of stimulating hair growth using benzopyrans |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004019927A3 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003020297A8 Method of improving wound healing |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040132988 Immunoeffector compounds |
| 07/08/2004 | US20040132984 Oligonuclelotide sequences for use in controlling expression and translation of neutrophil gelatinase associated lipocalin (NGAL) and treatment and prevention of inflammatory bowel disease: RNA interference; gene expression inhibition |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132750 Acyl guanidine compounds and use thereof |
| 07/08/2004 | US20040132748 Novel adenne derivatives |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132729 Inhibitors of p38 |
| 07/08/2004 | US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations |
| 07/08/2004 | US20040132724 e.g., cis-1-Acetyl-6-ethyl-N-(4-ethylphenyl)-1,2,3,4-tetrahydro-2-methyl-4-quinolinamine; atopic dermatitis, urticaria, various allergies bullous pemphigoid, industrial sensitization, chronic transplant rejection and COPD |
| 07/08/2004 | US20040132701 Steroid hormones, especially the oestrogens |
| 07/08/2004 | US20040132699 Skin disorders |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040132686 C2,5'- disubstituted and N6, c2,5'- trisubstituted adenosine derivatives and their different uses |
| 07/08/2004 | US20040132685 Immunostimulatory nucleic acid |
| 07/08/2004 | US20040132639 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 07/08/2004 | US20040132636 Pharmaceutical uses for alpha2delta ligands |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132057 Tumor necrosis related receptor,TR7 |
| 07/08/2004 | US20040132038 Membrane protein for use as diagnostic tool in the detection and prevention of cell proliferative, cardiovascular, skin, nervous system, respiratory and metabolic disorders |
| 07/08/2004 | US20040132022 Comprises nucleotide sequences coding growth factor for treatment and prevention of aberrations in cellular growth and differentiation; cancer diagnosis and treatment; antitumor agents |
| 07/08/2004 | US20040131710 Methods for treating skin conditions |
| 07/08/2004 | US20040131706 Pharmaceutical preparation |
| 07/08/2004 | US20040131703 Antiinflammatory agents; respiratory system disorders |
| 07/08/2004 | US20040131702 Mixture with acid |
| 07/08/2004 | US20040131688 Mixture of biological tissue, particles and confining liquid; stability; three-dimensional; absorption, decomposition of toxicity ; encapsulation of bacteria |
| 07/08/2004 | US20040131645 Polysaccharide based gel |
| 07/08/2004 | US20040131589 Materials and methods for inhibition of IgE production |
| 07/08/2004 | US20040131583 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/08/2004 | US20040131566 Fine titanium particles in water dispersion; combustion mixture of hydrogen and oxygen in high pressure water; using combustion gas to melt titanium |
| 07/08/2004 | US20040131564 Use of active ingredient combinations consisting of alpha-lipoic acid and dermatologically compatible substances that absorb light in the uv-a and or uv-b wavelength range(s) for producing cosmetic or dermatological preparations |
| 07/08/2004 | US20040131563 Therapy for pigmenting diseases; skin disorders |
| 07/08/2004 | DE10260955A1 Verwendung von Steroidsulfatase-Inhibitoren zur Verminderung von Haarausfall Use of steroid sulfatase inhibitors to reduce hair loss |
| 07/08/2004 | DE10163190B4 Pflanzliche Wirkstoffmischung zur Linderung von Haar- und Hautleiden Herbal ingredient mixture to alleviate suffering hair and skin |
| 07/08/2004 | CA2510711A1 Novel aminobenzophenone compounds |
| 07/08/2004 | CA2508624A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |